Cargando…
Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper
Patients with cancer are at higher risk of more severe COVID-19 infection and have more associated complications. The position paper describes the management of cancer patients, especially those receiving anticancer treatment, during the COVID-19 pandemic. Dyspnea is a common emergency presentation...
Autores principales: | Cooksley, Tim, Font, Carme, Scotte, Florian, Escalante, Carmen, Johnson, Leslie, Anderson, Ronald, Rapoport, Bernardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682766/ https://www.ncbi.nlm.nih.gov/pubmed/33230644 http://dx.doi.org/10.1007/s00520-020-05906-y |
Ejemplares similares
-
A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative
por: Leon Rapoport, Bernardo, et al.
Publicado: (2023) -
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity
por: Shannon, Vickie R., et al.
Publicado: (2020) -
Use of MASCC score in the inpatient management of febrile neutropenia: a single-center retrospective study
por: Bhardwaj, Prarthna V., et al.
Publicado: (2021) -
Can MASCC and CISNE scores predict delays of lung cancer chemotherapy after febrile neutropenia?
por: Ono, Yoshitaka, et al.
Publicado: (2022) -
Emergency management of incidental pulmonary embolism (IPE)
por: Font, Carme, et al.
Publicado: (2022)